Jéssika De Oliveira Viana

Mrs. Jéssika De Oliveira Viana

Post-Graduate Program in Bioinformatic, Federal University of Rio Grande do Norte
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2024 in Mini-Reviews in Medicinal Chemistry
Verified
Journal Article
Open access
PDF file
Igor José dos Santos NascimentoIgor José dos Santos Nascimento
Igor José dos Santos Nascimento
JGJoilly Nilce Santana Gomes
Joilly Nilce Santana Gomes
Jéssika De Oliveira VianaJéssika De Oliveira Viana
Jéssika De Oliveira Viana
YSYvnni Maria Sales de Medeiros e Silva
Yvnni Maria Sales de Medeiros e Silva
EBEUZEBIO GUIMARAES BARBOSA
EUZEBIO GUIMARAES BARBOSA
RMRicardo Olímpio de Moura
Ricardo Olímpio de Moura
A large family of enzymes with the function of hydrolyzing peptide bonds, called peptidases or cysteine proteases (CPs), are divided into three categories according to the peptide chain involved. CPs catalyze the hydrolysis of amide, ester, thiol ester, and thioester peptide bonds. They can be divided into several groups, such as papain-like (CA), viral chymotrypsin-like CPs (CB), papainlike endopeptidases of RNA viruses (CC), legumain-type caspases (CD), and showing active residues of His, Glu/Asp, Gln, Cys (CE). The catalytic mechanism of CPs is the essential cysteine residue present in the active site. These mechanisms are often studied through computational methods that provide new information about the catalytic mechanism and identify inhibitors. The role of computational methods during drug design and development stages is increasing. Methods in Computer-Aided Drug Design (CADD) accelerate the discovery process, increase the chances of selecting more promising molecules for experimental studies, and can identify critical mechanisms involved in the pathophysiology and molecular pathways of action. Molecular dynamics (MD) simulations are essential in any drug discovery program due to their high capacity for simulating a physiological environment capable of unveiling significant inhibition mechanisms of new compounds against target proteins, especially CPs. Here, a brief approach will be shown on MD simulations and how the studies were applied to identify inhibitors or critical information against cysteine protease from several microorganisms, such as Trypanosoma cruzi (cruzain), Trypanosoma brucei (rhodesain), Plasmodium spp. (falcipain), and SARS-CoV-2 (Mpro). We hope the readers will gain new insights and use our study as a guide for potential compound identifications using MD simulations.

5 May 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Jéssika De Oliveira VianaJéssika De Oliveira Viana
Jéssika De Oliveira Viana
ESEden Silva e Souza
Eden Silva e Souza
NSNicolau Sbaraini
Nicolau Sbaraini
MVMarilene Vainstein
Marilene Vainstein
JGJoilly Nilce Santana Gomes
Joilly Nilce Santana Gomes
EBEUZEBIO GUIMARAES BARBOSA
EUZEBIO GUIMARAES BARBOSA
The concept of “one target, one drug, one disease” is not always true, as compounds with previously described therapeutic applications can be useful to treat other maladies. For example, acridine derivatives have several potential therapeutic applications. In this way, identifying new potential targets for available drugs is crucial for the rational management of diseases. Computational methodologies are interesting tools in this field, as they use rational and direct methods. Thus, this study focused on identifying other rational targets for acridine derivatives by employing inverse virtual screening (IVS). This analysis revealed that chitinase enzymes can be potential targets for these compounds. Subsequently, we coupled molecular docking consensus analysis to screen the best chitinase inhibitor among acridine derivatives. We observed that 3 compounds displayed potential enhanced activity as fungal chitinase inhibitors, showing that compound 5 is the most active molecule, with an IC50 of 0.6 ng/µL. In addition, this compound demonstrated a good interaction with the active site of chitinases from Aspergillus fumigatus and Trichoderma harzianum. Additionally, molecular dynamics and free energy demonstrated complex stability for compound 5. Therefore, this study recommends IVS as a powerful tool for drug development. The potential applications are highlighted as this is the first report of spiro-acridine derivatives acting as chitinase inhibitors that can be potentially used as antifungal and antibacterial candidates.

Verified
Journal Article
Open access
PDF file
RBRenata Barros
Renata Barros
Jéssika De Oliveira VianaJéssika De Oliveira Viana
Jéssika De Oliveira Viana
EMEugene Muratov
Eugene Muratov
LUCIANA SCOTTILUCIANA SCOTTI
LUCIANA SCOTTI
Marcus ScottiMarcus Scotti
Marcus Scotti
Schistosomiasis is a chronic parasitic disease caused by trematodes of the genus Schistosoma; it is commonly caused by Schistosoma mansoni, which is transmitted by Bioamphalaria snails. Studies show that more than 200 million people are infected and that more than 90% of them live in Africa. Treatment with praziquantel has the best cost–benefit result on the market. However, hypersensitivity, allergy, and drug resistance are frequently presented after administration. From this perspective, ligand-based and structure-based virtual screening (VS) techniques were combined to select potentially active alkaloids against S. mansoni from an internal dataset (SistematX). A set of molecules with known activity against S. mansoni was selected from the ChEMBL database to create two different models with accuracy greater than 84%, enabling ligand-based VS of the alkaloid bank. Subsequently, structure-based VS was performed through molecular docking using four targets of the parasite. Finally, five consensus hits (i.e., five alkaloids with schistosomicidal potential), were selected. In addition, in silico evaluations of the metabolism, toxicity, and drug-like profile of these five selected alkaloids were carried out. Two of them, namely, 11,12-methylethylenedioxypropoxy and methyl-3-oxo-12-methoxy-n(1)-decarbomethoxy-14,15-didehydrochanofruticosinate, had plausible toxicity, metabolomics, and toxicity profiles. These two alkaloids could serve as starting points for the development of new schistosomicidal compounds based on natural products.

1 January 2020 in Brazilian Oral Research
Verified
Journal Article
Open access
PDF file
TCTereza Karla Vieira Lopes da Costa
Tereza Karla Vieira Lopes da Costa
MBMariana Silva Barros
Mariana Silva Barros
RBRenan Marrinho Braga
Renan Marrinho Braga
Jéssika De Oliveira VianaJéssika De Oliveira Viana
Jéssika De Oliveira Viana
FSFrederico Barbosa de Sousa
Frederico Barbosa de Sousa
RCRicardo Castro
Ricardo Castro
We aimed to evaluate the orofacial antinociceptive effect of geraniol in mice and its molecular anchorage mechanism. Seven mice per group (probabilistic sample) were treated with geraniol (12.5, 25 and 50 mg/kg, i.p.), morphine (6 mg/kg, i.p.) and vehicle (saline + Tween 80 at 0.2%, i.p.) 30 minutes prior to the beginning of the experiment. Injecting glutamate (25 μM), capsaicin (2.5 μg) and formalin (2%) into the right upper lip (perinasal) of the mouse induced nociception. Behavioral analysis of the animals considered the friction time (in seconds) of the mentioned region using hind or front paws by a researcher blinded to the treatment groups. The statistical analysis was performed blindly, considering α = 5%. The results showed that in the glutamate and capsaicin tests, concentrations of 25 mg/kg and 50 mg/kg presented antinociceptive activity (p < 0.005, power> 80%). In the formalin test, geraniol was able to reduce nociception at a concentration of 50 mg/kg (p < 0.005, power> 80%). In the molecular anchorage study, high values of binding between the evaluated substance and receptors of glutamate were observed (metabotropic glutamate receptor, -87.8501 Kcal/mol; N-methyl-D-aspartate, -86.4451 Kcal/mol; α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid, -85.6755 Kcal/mol). Geraniol presented orofacial antinociceptive activity, probably by interacting with glutamate-related receptors.

7 May 2024 in Biocatalysis and Agricultural Biotechnology
Verified
Journal Article
Closed access
WPWilza Kımilly Vital de Paiva
Wilza Kımilly Vital de Paiva
LOLuana Beatriz de Sales Oliveira
Luana Beatriz de Sales Oliveira
MSMaria Carolina Neves Silva
Maria Carolina Neves Silva
MOMaria Luiza Pedrosa Lima Oliveira
Maria Luiza Pedrosa Lima Oliveira
JMJosé Wilkson de Almeida Maia
José Wilkson de Almeida Maia
ESEveraldo Silvino Dos Santos
Everaldo Silvino Dos Santos

20 August 2025 in Journal of Chemical Information and Modeling
Verified
Journal Article
Open access
IBIverson Conrado Bezerra
Iverson Conrado Bezerra
Jéssika De Oliveira VianaJéssika De Oliveira Viana
Jéssika De Oliveira Viana
KWKaren Cacilda Weber
Karen Cacilda Weber
PGPriscila Gubert
Priscila Gubert
Molecular dynamics (MD) simulations generate extensive data sets that demand reliable and reproducible analysis tools. In this study, we present DynamiSpectra, a Python-based software package and web platform designed to automate the descriptive statistical analysis (mean and standard deviation) and visualization of MD trajectories. DynamiSpectra enables streamlined processing of GROMACS-generated files, supporting comparative analyses across multiple simulation replicas without requiring topology file handling or programming expertise. The package performs key structural and dynamic analyses, including RMSD, RMSF, radius of gyration, SASA, hydrogen bonds, salt bridges, secondary structure probability and fraction, principal component analysis, and ligand occupancy maps, producing high-quality graphical outputs with integrated descriptive statistical analysis. Additionally, it supports analyses such as protein-ligand contacts, protein-ligand minimum distance, protein-ligand hydrophobic contacts, inter-residue distance matrices, phi and psi angles, rotamers (χ1 and χ2), ligand dihedral angles, as well as analyses of pressure, temperature, and density within the system. Comparative tests performed against widely used MD analysis packages revealed that the results generated by DynamiSpectra were consistent with those tools. DynamiSpectra stands out for its ability to automate the analysis of multiple replicas, as well as the calculation of mean and standard deviation, which other packages often lack in automation. A use case involving β-amyloid peptide simulations at different temperatures illustrates the platform's capabilities. Furthermore, the DynamiSpectra web interface enables users to upload data, generate interactive plots, and explore results without requiring local installation, thereby promoting accessible and reproducible MD analysis, being another essential distinguishing feature of the tool. The software is freely available via PyPI (https://pypi.org/project/DynamiSpectra/) and GitHub (https://github.com/Conradoou/DynamiSpectra/tree/main). The online web server can be accessed at: https://dynamispectra.onrender.com.